LM N°2/ 2024 INTRODUCTION TO THE SAGA: IF HYALURONIC ACID WERE CONTROLLED TO ME... Pr AC Benhamou

All you want to know... IF THE HYALURONIC ACID SAGA WAS TOLD TO ME... the magic molecule... Pr Albert Claude BENHAMOUPast-President of the Académie Nationale de Chirurgie More than a century of research in fundamental, applied and industrial biochemistry was needed to bring to the fore in human and veterinary medicine the multiple uses of hyaluronic acid, known as [...].
LM N°2/ 2024. AH'S FLAGSHIP CLINICAL APPLICATIONS. Aesthetic facial health and HA. LIP ENHANCEMENT: A NATURAL AND SUBTLE APPROACH. Céline DOLLANGÈRE, MD.

AH'S FLAGSHIP CLINICAL APPLICATIONS. Facial Aesthetic Health and HA LIP ENHANCEMENT: A NATURAL AND SUBTLE APPROACH. Céline DOLLANGÈRE, MD. Aesthetic Physician, Roissy en France "We must sublimate without transforming!" Abstract From ancient times to the present day, lips have always been a symbol of sensuality and attractiveness, and the [...]
LM N°2/ 2024. The state of the art in 2024. HYALURONIC ACID, FROM THE ENDOGENOUS MOLECULE TO INJECTABLE GELS. Denis COUCHOUREL.

The state of the art in 2024 HYALURONIC ACID: FROM ENDOGENIC MOLECULE TO INJECTABLE GELS Denis COUCHOUREL, PhD Scientific and Medical Director, Laboratoires VIVACY ENDOGENIC HYALURONIC ACID In 1934, Karl Meyer and John Palmer described a new polysaccharide initially isolated from bovine vitreous humor. This substance contained a uronic acid and a sugar [...].
LM N°2/ 2024. The state of the art in 2024.rHEOLOGICAL CHARACTERIZATION OF STYLAGE® FILLING PRODUCTS WITH REGARD TO THEIR INJECTION PLANS AND CLINICAL PERFORMANCE. Virginie BIGAND, Ph.D, Florence BRUNEL, Ms.c, Frédéric TRANCHEPAIN, Ph.D.

STATE OF THE ART IN AH RESEARCH RHEOLOGICAL CHARACTERIZATION OF STYLAGE® DERMAL FILLERS WITH REGARD TO THEIR INJECTION SCHEDULES AND CLINICAL PERFORMANCE. Virginie BIGAND, Ph.D., Florence BRUNEL, Ms.c., Frédéric TRANCHEPAIN, Ph.D. Figure 1. IPN-like® interpenetrating network INTRODUCTION: RETICULATION OF HA. WHY? The aging process of the skin is characterized, among other things, by [...].
LM N°2/ 2024. ACT 1. THE SAGA OF KARL MEYER. THE DISCOVERER OF AH.

THE STORY OF A YOUNG JEWISH DOCTOR AND BIOCHEMIST
GERMAN, WHO EMIGRATED TO THE USA IN 1930 TO ESCAPE
THE NAZI REGIME. HE DISCOVERS ACID
HYALURONIC. A LONG STORY BEGINS
120 YEARS AGO.
LM N°2/ 2024. ACT 2. THE SAGA OF ENDRE ALEXANDER BALAZS' YEARS OF RESEARCH

THE HUNGARIAN DOCTOR AND RESEARCHER WHO WAS TO BECOME
THE LEADER IN APPLIED RESEARCH AND
ON HYALURONIC ACID.
A SUCCESS STORY BASED ON INTUITION AND TENACITY
FROM RESEARCHER TO WEALTHY INDUSTRIALIST
LM N°2/ 2024. ACT 3. THE SAGA OF INDUSTRIAL DEVELOPMENT. FROM BIOMATRIX TO VIVACY TO Q-MED...

SI LA SAGA DE L’AH M’ÉTAIT CONTÉE… ACTE 3. LA SAGA DU DÉVELOPPEMENT INDUSTRIEL.DE BIOMATRIX À Q-MED EN PASSANT PAR VIVACY… Cette saga est racontée dans tous ses détails à partir du travail de Börje Svensson : «The magic molecule – that has improved the lives of millions.» https://books.google.fr/books/about/The_Magic_Molecule_ that_Has_Improved_the.html?id=fmETDAEACAAJ&redir_esc=y “My book, «The Magic Molecule […]
LM N°2/ 2024. ACT 4. THE SAGA OF WALDEMAR KITA: the founder of VIVACY. "Efficient research and quality products and service are the keys to success".

Si la saga de l’AH m’était contée… ACTE 4. LA SAGA DE WALDEMAR KITA : le fondateur de VIVACY. De la fabrication des lentilles intra-oculaires avec la création de la Société CORNEAL en 1987, aux applications de l’acide hyaluronique à base de crêtes de coqs utilisées en chirurgie de la cataracte et du glaucome, puis […]
LM N°2/ 2024. What is the state of hyaluronic acid R&D, today and tomorrow? Michel CHERON PDt and CEO of the VIVACY Group Interview by Pr AC BENHAMOU

Hyaluronic acid is at the heart of your industrial research and the development of medical applications for hyaluronic acid. Can you tell us about Vivacy's current development in this sector?
LM N°2/ 2024. HA's flagship clinical applications. Aesthetic health in oncology and HA. THE IMPACT OF HYALURONIC ACID INJECTIONS ON THE PHYSICAL AND PSYCHOLOGICAL ASPECTS OF CANCER PATIENTS. Dr Fanny POIROT

IMPACT OF HYALURONIC ACID INJECTIONS ON PHYSICAL AND PSYCHICAL ASPECTS OF CANCER PATIENTS Dr Fanny POIROT Medical Director, Centre Médical Pasteur. Center de Médecine Esthétique et Réparatrice, 91800 Brunoy Abstract Hyaluronic acid (HA) injections in aesthetic medicine represent a promising advance in improving the [...]